Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Cell Host & Microbe

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.  27:976-991. 2020
  • Salmonella Typhoid Toxin PltB Subunit and Its Non-typhoidal Salmonella Ortholog Confer Differential Host Adaptation and Virulence.  27:937-946. 2020
  • Human Influenza Virus Hemagglutinins Contain Conserved Oligomannose N-Linked Glycans Allowing Potent Neutralization by Lectins.  27:725-735. 2020
  • Rational Vaccine Design in the Time of COVID-19.  27:695-698. 2020
  • Convergent Evolution in Breadth of Two V(H)6-1-Encoded Influenza Antibody Clonotypes from a Single Donor.  28:434-444. 2020
  • Hemagglutinin Traits Determine Transmission of Avian A/H10N7 Influenza Virus between Mammals.  28:602-613. 2020
  • Influenza H7N9 virus neuraminidase-specific human monoclonal antibodies inhibit viral egress and protect from lethal influenza infection in mice.  26:715-728. 2019
  • Structural basis of protection against H7N9 influenza virus by human anti-N9 neuraminidase antibodies.  26:729-738. 2019
  • A meta-analysis of passive immunization studies shows that serum-neutralizing antibody titer associates with protection against SHIV challenge.  26:336-346. 2019
  • ARIH2 is a Vif-dependent regulator of CUL5-mediated APOBEC3G degradation in HIV infection.  26:86-99. 2019
  • Conformational plasticity in the HIV-1 fusion peptide facilitates recognition by broadly neutralizing antibodies.  25:873-883. 2019
  • Preventing an antigenically disruptive mutation in egg-based H3N2 seasonal influenza vaccines by mutational incompatibility.  25:836-844. 2019
  • Complement seals a virus to block infection.  25:482-483. 2019
  • A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates.  25:49-58. 2019
  • Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection.  25:39-48. 2019
  • Recurring and adaptable binding motifs in broadly neutralizing antibodies to influenza virus are encoded on the D3-9 segment of the Ig gene.  24:569-578. 2018
  • A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus.  24:221-233. 2018
  • The Marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding.  23:101-109. 2018
  • A highly pathogenic avian H7N9 influenza virus isolated from a human Is lethal in some ferrets infected via respiratory droplets.  22:615-626. 2017
  • Breaking the barrier: host cell invasion by Lujo virus.  22:583-585. 2017
  • SMYD2-mediated histone methylation contributes to HIV-1 latency.  21:569-579. 2017
  • Breaking down walls: Microbiota and the aging gut.  21:417-418. 2017
  • Transcriptional elongation of HSV immediate early genes by the super elongation complex drives lytic infection and reactivation from latency.  21:507-517. 2017
  • Recent H3N2 viruses have evolved specificity for extended, branched human-type receptors, conferring potential for increased avidity.  21:23-34. 2017
  • Diversity of functionally permissive sequences in the receptor-binding site of influenza hemagglutinin.  21:742-753. 2017
  • Intracellular action of a secreted peptide required for fungal virulence.  19:849-864. 2016
  • Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity.  19:504-514. 2016
  • Microbes without borders: decompartmentalization of the aging gut.  19:133-135. 2016
  • Meta- and orthogonal integration of influenza "OMICs'' data defines a role for UBR4 in virus budding.  18:723-735. 2015
  • Global mapping of the Inc-human interactome reveals that retromer restricts Chlamydia infection.  18:109-121. 2015
  • Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection.  17:653-661. 2015
  • New advances in the effort against Ebola.  17:545-547. 2015
  • A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors.  17:377-384. 2015
  • Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus.  17:369-376. 2015
  • Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins.  16:412-418. 2014
  • The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles.  14:522-534. 2013
  • Networking at the level of host immunity: immune cell interactions during persistent viral infections.  13:652-664. 2013
  • Proteome-wide quantification and characterization of oxidation-sensitive cysteines in pathogenic bacteria.  13:358-370. 2013
  • Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials.  13:227-237. 2013
  • The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.  13:452-464. 2013
  • A blueprint for HIV vaccine discovery.  12:396-407. 2012
  • Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.  12:558-570. 2012
  • An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.  12:97-108. 2012
  • An all-purpose antimalarial drug target.  11:555-557. 2012
  • Selective and specific inhibition of the plasmodium falciparum lysyl-trna synthetase by the fungal secondary metabolite cladosporin.  11:654-663. 2012
  • Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.  11:643-653. 2012
  • Pancreatic acinar cell-specific autophagy disruption reduces coxsackievirus replication and pathogenesis in vivo.  11:298-305. 2012
  • Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein.  11:205-217. 2012
  • Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner.  9:212-222. 2011
  • Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.  6:513-522. 2009
  • Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I.  5:439-449. 2009
  • Persistent virus infection inhibits type i interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.  4:374-386. 2008
  • Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.  4:239-248. 2008
  • Liver autoimmunity triggered by microbial activation of natural killer T cells.  3:304-315. 2008
  • Mechanism of adenovirus neutralization by human alpha-defensins.  3:11-19. 2008
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1931-3128

Electronic International Standard Serial Number (EISSN)

  • 1934-6069

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support